Skip to main
TEM
TEM logo

TEM Stock Forecast & Price Target

TEM Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 54%
Buy 15%
Hold 31%
Sell 0%
Strong Sell 0%

Bulls say

Tempus AI Inc is demonstrating a strong potential for growth, as reflected in the raised price target based on a higher EV/sales multiple of 10.9x, highlighting anticipated 2026 sales of $1,568 million. This upward revision is indicative of the favorable valuation attributed to the foundation model's impact on the data and clinical businesses, emphasizing the company's commitment to enhance diagnostic accuracy through AI technology. Furthermore, the strategic partnership with AZN.LON and Pathos AI for a multimodal database aims to bolster oncology research, underscoring Tempus AI's position as a key player in transforming healthcare data utilization.

Bears say

Tempus AI Inc faces significant competitive pressures in the genomics testing market, which could adversely impact its market position and revenue generation. Additionally, the company is exposed to reimbursement risks associated with existing tests due to potential changes in policies from the Centers for Medicare & Medicaid Services (CMS) and other payors, as well as uncertainties surrounding the reimbursement landscape for newly introduced products like Algos. Furthermore, potential regulatory changes affecting patient and data privacy could hinder Tempus' ability to effectively acquire and utilize critical healthcare data, posing further threats to its operational capabilities.

TEM has been analyzed by 13 analysts, with a consensus rating of Buy. 54% of analysts recommend a Strong Buy, 15% recommend Buy, 31% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tempus AI Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tempus AI Inc (TEM) Forecast

Analysts have given TEM a Buy based on their latest research and market trends.

According to 13 analysts, TEM has a Buy consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $78.31, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $78.31, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tempus AI Inc (TEM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.